Home Prostate / Prostate Cancer Nuview Life Sciences aims to take the guesswork out of cancer diagnosis...

Nuview Life Sciences aims to take the guesswork out of cancer diagnosis | 2020-12-23

48
0

Clinical-stage oncology company Nuview Life Sciences Inc. is developing a cancer diagnostic test and treatment delivery system that could reduce the need for costly, less accurate tests and surgical biopsies. The binary – yes/no – test employs a proprietary peptide construct, NV-VPAC1, that targets a specific receptor, called vasoactive intestinal peptide receptor type 1 (VPAC1), that is overexpressed on the surface of cancer cells.

BioWorld MedTech Cancer Diagnostics U.S.

https://www.bioworld.com/articles/501750-nuview-life-sciences-aims-to-take-the-guesswork-out-of-cancer-diagnosis

This site uses Akismet to reduce spam. Learn how your comment data is processed.